Bray, Sarah
Amgen (United Kingdom)
4 papers on CoChatORCID 0000-0002-4867-574X
Most cited papers
- Verified
EU-Wi d e Cross-Section a l Obser v at i o n al Study of Lipid-Modifying Therapy Use in Se c ondary and Pr i mary Care: the DA VINCI study
Ray, K. K., Molemans, B., Schoonen, W. M., Giovas, P., Bray, S., Kiru, G., Murphy, J., Banach, M., De Servi, S., Gaita, D., et al. (2021) · European Journal of Preventive Cardiology
Lipoproteins and Cardiovascular HealthBlood Pressure and Hypertension Studies
Cited by 839
- Verified
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study
Vrablik, M., Seifert, B., Parkhomenko, A., Banach, M., Jóźwiak, J. J., Kiss, R. G., Gaita, D., Rašlová, K., Zachlederova, M., Bray, S., et al. (2021) · Atherosclerosis
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 83
- Verified
Network meta-analysis of randomized trials evaluating the comparative efficacy of lipid-lowering therapies added to maximally tolerated statins for the reduction of low-density lipoprotein cholesterol
Toth, P. P., Bray, S., Villa, G., Palagashvili, T., Sattar, N., Stroes, E. S. G., & Worth, G. M. (2022) · Journal of the American Heart Association
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 56
- Verified
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
van de Borne, P., Peeters, A., Janssens, L., Leone, A., Lemmens, R., Verhaegen, A., De Meulemeester, M., Balthazar, Y., Heijmans, S., Calozet, Y., et al. (2024) · Acta Cardiologica
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free